1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Raghothama, S.
Simpson, P.J.
Gilbert, H.J.
Williamson, M.P.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
Biochemistry
BICHAW
0033
0006-2960
39
978
10.1021/BI992163+
10653641
Solution Structure of the Cbm10 Cellulose Binding Module from Pseudomonas Xylanase A
2000
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
5400.007
ENDO-1,4-BETA-XYLANASE
3.2.1.8
TYPE X CELLULOSE BINDING DOMAIN (CBDX)
1
man
polymer
no
no
MGNQQCNWYGTLYPLCVTTTNGWGWEDQRSCIARSTCAAQPAPFGIVGSG
MGNQQCNWYGTLYPLCVTTTNGWGWEDQRSCIARSTCAAQPAPFGIVGSG
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
sample
294
PSEUDOMONAS FLUORESCENS
562
ESCHERICHIA COLI
PLASMID
BL21
repository
Initial release
Version format compliance
Version format compliance
1
0
2000-10-03
1
1
2011-05-08
1
2
2011-07-13
2000-10-03
SPRSDE
CATALYTIC CORE OF XYLANASE A
SOLUTION STRUCTURE OF TYPE X CBD
SOLUTION STRUCTURE OF TYPE X CBM
HELIX
DETERMINATION METHOD: AUTHOR PROVIDED.
SHEET
DETERMINATION METHOD: AUTHOR PROVIDED.
PDBE
Y
PDBE
2000-09-28
REL
THE STRUCTURE WAS DETERMINED USING STANDARD 2D HOMONUCLEAR TECHNIQUES.
5 STRUCTURES CHOSEN AT RANDOM FROM THE 21 LOWEST ENERGY STRUCTURES
50
5
2D NOESY
DQF-COSY
E-COSY
100MM NACL
4.50
pH
AMBIENT
323.00
K
YASAP
DISTANCE GEOMETRY, SIMULATED ANNEALING
1MM CBDX
50MM SODIUM PHOSPHATE BUFFER
100MM SODIUM CHLORIDE
BRUNGER
refinement
X-PLOR
3.1
structure solution
FELIX
97.0
structure solution
X-PLOR
3.1
500
Bruker
DRX
600
Bruker
DRX
MET
20
n
1
MET
20
A
GLY
21
n
2
GLY
21
A
ASN
22
n
3
ASN
22
A
GLN
23
n
4
GLN
23
A
GLN
24
n
5
GLN
24
A
CYS
25
n
6
CYS
25
A
ASN
26
n
7
ASN
26
A
TRP
27
n
8
TRP
27
A
TYR
28
n
9
TYR
28
A
GLY
29
n
10
GLY
29
A
THR
30
n
11
THR
30
A
LEU
31
n
12
LEU
31
A
TYR
32
n
13
TYR
32
A
PRO
33
n
14
PRO
33
A
LEU
34
n
15
LEU
34
A
CYS
35
n
16
CYS
35
A
VAL
36
n
17
VAL
36
A
THR
37
n
18
THR
37
A
THR
38
n
19
THR
38
A
THR
39
n
20
THR
39
A
ASN
40
n
21
ASN
40
A
GLY
41
n
22
GLY
41
A
TRP
42
n
23
TRP
42
A
GLY
43
n
24
GLY
43
A
TRP
44
n
25
TRP
44
A
GLU
45
n
26
GLU
45
A
ASP
46
n
27
ASP
46
A
GLN
47
n
28
GLN
47
A
ARG
48
n
29
ARG
48
A
SER
49
n
30
SER
49
A
CYS
50
n
31
CYS
50
A
ILE
51
n
32
ILE
51
A
ALA
52
n
33
ALA
52
A
ARG
53
n
34
ARG
53
A
SER
54
n
35
SER
54
A
THR
55
n
36
THR
55
A
CYS
56
n
37
CYS
56
A
ALA
57
n
38
ALA
57
A
ALA
58
n
39
ALA
58
A
GLN
59
n
40
GLN
59
A
PRO
60
n
41
PRO
60
A
ALA
61
n
42
ALA
61
A
PRO
62
n
43
PRO
62
A
PHE
63
n
44
PHE
63
A
GLY
64
n
45
GLY
64
A
ILE
65
n
46
ILE
65
A
VAL
66
n
47
VAL
66
A
GLY
67
n
48
GLY
67
A
SER
68
n
49
SER
68
A
GLY
69
n
50
GLY
69
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
A
N
CYS
25
A
N
CYS
6
A
O
TYR
32
A
O
TYR
13
A
O
PRO
33
A
O
PRO
14
A
N
ILE
51
A
N
ILE
32
A
O
CYS
50
A
O
CYS
31
A
N
GLY
43
A
N
GLY
24
1
A
ARG
48
0.203
SIDE CHAIN
1
A
ARG
53
0.317
SIDE CHAIN
2
A
ARG
48
0.207
SIDE CHAIN
2
A
ARG
53
0.309
SIDE CHAIN
3
A
ARG
48
0.279
SIDE CHAIN
3
A
ARG
53
0.318
SIDE CHAIN
4
A
ARG
48
0.222
SIDE CHAIN
4
A
ARG
53
0.242
SIDE CHAIN
5
A
ARG
48
0.195
SIDE CHAIN
5
A
ARG
53
0.231
SIDE CHAIN
1
A
ASN
26
-62.15
92.13
1
A
TYR
28
37.73
26.01
1
A
ASN
40
-82.72
41.46
1
A
GLN
47
59.36
16.25
1
A
ALA
52
-41.09
168.04
1
A
ARG
53
-56.30
-79.06
1
A
CYS
56
-72.67
-76.67
2
A
TYR
28
37.25
27.00
2
A
ASN
40
-84.10
43.50
2
A
ALA
52
-41.97
167.85
2
A
ARG
53
-58.19
-78.25
2
A
CYS
56
-85.25
-74.06
2
A
ALA
58
-90.36
31.66
3
A
TYR
28
28.66
37.89
3
A
ASN
40
-83.18
42.52
3
A
GLN
47
59.87
19.30
3
A
ALA
52
-40.32
165.41
3
A
ARG
53
-57.22
-77.45
3
A
CYS
56
-84.14
-76.13
3
A
SER
68
-123.92
-151.14
4
A
ASN
26
-59.95
93.58
4
A
TYR
28
35.05
29.69
4
A
ASN
40
-82.63
41.21
4
A
GLN
47
58.88
16.87
4
A
ALA
52
-41.75
168.18
4
A
ARG
53
-56.46
-79.06
4
A
CYS
56
-72.24
-76.75
5
A
TRP
27
-68.97
95.01
5
A
TYR
28
31.85
32.60
5
A
ASN
40
-82.64
41.43
5
A
GLN
47
59.29
16.50
5
A
ALA
52
-40.46
166.07
5
A
ARG
53
-56.27
-77.75
5
A
CYS
56
-76.51
-75.49
5
A
GLN
59
-44.85
161.58
ENDO-1,4-BETA-XYLANASE (E.C.3.2.1.8)
SOLUTION STRUCTURE OF TYPE X CBD
1
N
N
A
ARG
53
A
ARG
34
HELX_P
A
ALA
57
A
ALA
38
1
1
5
disulf
2.008
A
CYS
25
A
SG
CYS
6
1_555
A
CYS
56
A
SG
CYS
37
1_555
disulf
2.021
A
CYS
35
A
SG
CYS
16
1_555
A
CYS
50
A
SG
CYS
31
1_555
HYDROLASE
HYDROLASE, BETA STRANDS, ANTIPARALLEL SHEETS
A
ALA
61
A
ALA
42
1
A
PRO
62
A
PRO
43
0.26
A
ALA
61
A
ALA
42
2
A
PRO
62
A
PRO
43
0.11
A
ALA
61
A
ALA
42
3
A
PRO
62
A
PRO
43
-0.04
A
ALA
61
A
ALA
42
4
A
PRO
62
A
PRO
43
0.28
A
ALA
61
A
ALA
42
5
A
PRO
62
A
PRO
43
-0.16
XYNA_PSEFL
UNP
1
P14768
179
228
1E8R
20
69
P14768
A
1
1
50
1
SER
cloning artifact
MET
20
1E8R
A
S06047
PIR
179
1
4
anti-parallel
parallel
anti-parallel
A
GLN
24
A
GLN
5
A
ASN
26
A
ASN
7
A
LEU
31
A
LEU
12
A
CYS
35
A
CYS
16
A
ARG
48
A
ARG
29
A
ALA
52
A
ALA
33
A
TRP
42
A
TRP
23
A
GLU
45
A
GLU
26
1
P 1